EPISODE · Apr 23, 2026 · 25 MIN
Challenging the Confines of Risk of Recurrence in High-Risk HR+/HER2- Early Breast Cancer
from Keeping Current CME
Are you confident in identifying the risk for recurrence in early-stage HR-positive, HER2-negative breast cancer? Credit available for this activity expires: [04/21/27] Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/challenging-confines-risk-recurrence-high-risk-hr-her2-early-2026a1000bq3?ecd=bdc_podcast_libsyn_mscpedu
Embed this episode
NOW PLAYING
Challenging the Confines of Risk of Recurrence in High-Risk HR+/HER2- Early Breast Cancer
No transcript for this episode yet
Similar Episodes
No similar episodes found.
Similar Podcasts
No similar podcasts found.